InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,726.20
(
0.46%
)
US TECH 100
19,394.80
(
0.68%
)
Dow Jones
42,124.96
(
0.27%
)
Brent Oil
78.32
(
0.66%
)
Bitcoin
61,670.21
(
1.51%
)
Post# of 3329
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

califax

Send PM Follow Ignore
Followers 24
Posts 3015
Boards Moderated 0
Alias Born 01/18/2009

califax

Re: chmcnfunds post# 1072

Saturday, 01/15/2011 4:11:47 AM

Saturday, January 15, 2011 4:11:47 AM

Post# of 3329
...a long way to go

The company said in November that a late-stage trial of Zerenex met its goals in treating a phosphate imbalance in kidney dialysis patients.

A long-term safety study of the drug is ongoing, with results expected in the first half of 2012, the CEO said.


A study of Perifisone in patients with advanced colorectal cancer who have stopped responding to other drugs is expected to conclude late this year.

posts are IMHO // either news - with LINK

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up